With Upcoming Space Launch, Adventurer Jaime Alemán Set to Complete the “Grand Slam” of Travel

Having Visited All 193 Countries and Both Poles, Alemán Now Eyes Space and a Human First Jaime Alemán of Panama, a distinguished lawyer and former senior diplomat, is about to make history-again. https://mma.prnewswire.com/media/2695523/e455a070_2795_463e_8ecd_a3975089ed63.jpg Panama's Aleman to Become First Human to Visit Space, All 193 Countries, and Both Poles. The pioneering space company Blue Origin announced […]

Middle Class May Finally Catch a Break as U.S. Eyes Major Tax Overhaul: Former White House Insider

BALTIMORE, May 25, 2025 (GLOBE NEWSWIRE) — For over a century, American workers have shouldered the tax burden that fuels the federal government. But that may soon change. According to Jim Rickards–a former White House advisor–Washington insiders are working on a plan that would eliminate income taxes for the middle class and redirect the country's

Industry Forums at 137th Canton Fair Spotlight Emerging Trends and Global Strategies

The 137th China Import and Export Fair (Canton Fair) hosted a series of high-level industry forums, bringing together government officials, financial institutions, business leaders, and subject matter experts. These sessions explored evolving global trade dynamics and offered strategic guidance to Chinese enterprises pursuing international growth. https://mma.prnewswire.com/media/2691606/image_969985_25683829.jpg A standout session on April 17, titled “The New

iQOO Neo 10 Debuts with Flagship Dual Chips, Delivering Breakthrough Performance and Industry-Leading Battery Life

iQOO officially unveils the latest addition to Neo lineup-iQOO Neo 10, featuring a powerful dual-chip setup that redefines performance in its class. With next-level performance powered by a flagship-grade Snapdragon® platform and a cutting-edge Supercomputing Chip, a class-leading combination of a large-capacity battery and FlashCharge technology, and a high-refresh-rate, eyecare display built for gaming, iQOO

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases,announces that the results of a Phase 3 clinical study of mazdutide , a dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, in Chinese adults with

CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – CERE

(NASDAQ:CERE), NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class

CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – CERE

CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – CERE GlobeNewswire May 25, 2025 NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm,

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM

(NYSE:ATNM), NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive (the “Class Period”), of the important May 27, 2025 lead plaintiff deadline. SO WHAT:

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM GlobeNewswire May 25, 2025 NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law

Scroll to Top